Novavax
NVAX
250 hedge funds and large institutions have $643M invested in Novavax in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 80 increasing their positions, 52 reducing their positions, and 43 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 52
19% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 43
2% more funds holding
Funds holding: 245 → 250 (+5)
2% more capital invested
Capital invested by funds: $632M → $643M (+$10.7M)
0.79% more ownership
Funds ownership: 61.31% → 62.1% (+0.79%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
31% less call options, than puts
Call options by funds: $52.9M | Put options by funds: $76.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$13.1M |
| 2 |
Millennium Management
New York
|
+$7.69M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.04M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.6M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$4.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$16.2M |
| 2 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
-$8.95M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$6.32M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.55M |
| 5 |
Morgan Stanley
New York
|
-$4.89M |
NVAX Hedge Fund Activity: Q2 2025 in Review
250 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2025, worth a combined $643M — up 1.7% from $632M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new NVAX positions and 43 closed out — a net gain of 8 holders — while 80 added to existing stakes and 52 trimmed.
The largest buyer was Bank of America, adding an estimated $13.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $16.2M sold.
- 250 institutional investors held Novavax (NVAX) as of Q2 2025, up from 245 in Q1 2025.
- Funds reported $643M of Novavax stock for Q2 2025, up 1.7% quarter-over-quarter.
- 51 funds opened new Novavax positions in Q2 2025 and 43 closed out, a net change of +8 holders.
- The largest Novavax buyer in Q2 2025 was Bank of America, an estimated $13.1M added.
- The largest Novavax seller in Q2 2025 was Park West Asset Management, an estimated $16.2M sold.
Based on aggregated 13F filings for Q2 2025.